Health Care Enforcement Year in Review & 2022 Outlook

M
Mintz
Details
Date & Time
16 Feb 2022 | 5:00 PM UTC
Duration
1 hour
Language
English
Photo of Karen Lovitch
Photo of Kevin McGinty
Photo of Samantha Kingsbury
Photo of Grady Campion
Photo of Randy Jones
Speakers
United States
Watch on demand
To print this article, all you need is to be registered or login on Mondaq.com.

In the first year of the Biden administration, health care fraud remained an enforcement priority for the Department of Justice (DOJ) and other federal agencies. While criminal enforcement actions continued to focus on the opioid crisis, the civil False Claims Act (FCA) is still one of the government’s most powerful enforcement tools. In our annual webinar, Mintz’s Health Care Enforcement Defense team will review the key health care fraud enforcement developments and trends from 2021, assess their likely impact in 2022, and provide recommendations to avoid government scrutiny.

Topics will include:

• Statistical analysis of trends in False Claims Act litigation involving the health care industry
• DOJ’s health care fraud enforcement priorities, including Opioids, Covid-19, Medicare Advantage risk adjustment practices, telefraud, and misconduct in clinical trials 
• Overview of federal agency guidance and policy developments in 2021, including DOJ’s renewed focus on individual and corporate accountability 
• Predictions for health care enforcement activity in 2022 

Registrants will receive Mintz's Health Care Enforcement 2021 Year in Review & 2022 Outlook, which will cover all these issues and more.

CLE Credit:
Mintz is an approved CLE provider. This seminar is accredited in the following states: California (1.00 general credits) and New York (1.00 credits in the Areas of Professional Practice).

Register

All Mondaq Webinar's are free to access.

To view and register to this webinar please sign up below

Watch on demand

Health Care Enforcement Year in Review & 2022 Outlook

United States

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More